Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H21N.ClH |
| Molecular Weight | 287.827 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C=C(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C
InChI
InChIKey=ZVTAYVQUGPGRAF-UHFFFAOYSA-N
InChI=1S/C18H21N.ClH/c1-15(19(2)3)14-18(16-10-6-4-7-11-16)17-12-8-5-9-13-17;/h4-15H,1-3H3;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin. | 1988 |
|
| Premedication for day-case surgery: double-blind comparison of ketobemidone + dimethylaminodiphenylbuten (A-29) and morphine + scopolamine. | 1986-10 |
|
| 5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats. | 1985-09 |
|
| Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29. | 1982-01 |
|
| Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration. | 1981-02 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
55011-89-7
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
1134299
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
100000093023
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
SUB13610MIG
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
DK0SQH68GQ
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
259-432-5
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
3047737
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
DTXSID80970373
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
SUB28884
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD